logo
16:01 Jan 20

MediCaps Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
30.89
+0.91 (+3.04%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

MediCaps Ltd. Financials

MediCaps Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
30.89
+0.91 (+3.04%)
16:01 Jan 20
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

24/100
Technically Bearish

Strength

6

Weakness

11

Opportunity

0

Threats

0

-0.47 %

ROE %

-0.45 %

ROA %

-4.52

EPS

97.25

BVPS

-2.24 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
57.42 69.87 49.37 27.35 25.48
Operating Expenses +
46.54 59.92 44.31 27.38 27.31
Raw Material
31.08 30.05 22.05 8.43 10.17
Increase Decrease in Cost
-1.71 0.06 0.85 1.09 0.48
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
6.71 7.71 7.69 7.07 7.58
Miscellaneous Expenses
10.46 22.1 13.72 10.79 9.08
Operating Profit
10.88 9.95 5.06 -0.03 -1.83
Other Income
1.89 1.91 1.6 0.48 2.73
Depreciation
1.52 1.81 1.74 1.69 1.72
Interest
0 0 0 0 0.02
Profit before tax and exceptio..
11.24 10.06 4.92 -1.25 -0.84
Exceptional Items
0 0 0 0 0
PBT
11.24 10.06 4.92 -1.25 -0.84
Provision for Taxation
-0.01 0.01 3.05 0.99 -0.27
Net Profit
11.13 10.08 1.76 -2.24 -0.57
NET Profit after MI
11.13 10.08 1.76 -2.24 -0.57
EPS
11.03 8.08 1.41 -1.8 -0.46
Operating Profit Margin (%)
18.95 14.24 10.25 -0.11 -7.18
Net Profit Margin (%)
19.38 14.43 3.56 -8.19 -2.24

MediCaps Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 50.80 50.80 50.80 50.80 50.60 50.40
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 49.20 49.20 49.20 49.20 49.40 49.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: